| Symbol |
Name |
|
AARS
|
alanyl-tRNA synthetase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABI3
|
ABI family, member 3
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ACYP1
|
acylphosphatase 1, erythrocyte (common) type
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
|
ADSL
|
adenylosuccinate lyase
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIRE
|
autoimmune regulator
|
|
AKNA
|
AT-hook transcription factor
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
|
ALG2
|
ALG2, alpha-1,3/1,6-mannosyltransferase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALX4
|
ALX homeobox 4
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANO5
|
anoctamin 5
|
|
ANOS1
|
anosmin 1
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARG1
|
arginase 1
|
|
ARHGAP4
|
Rho GTPase activating protein 4
|
|
ARHGEF11
|
Rho guanine nucleotide exchange factor (GEF) 11
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARX
|
aristaless related homeobox
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3
|
|
ATP6V1H
|
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN7
|
ataxin 7
|
|
AURKA
|
aurora kinase A
|
|
AUTS2
|
autism susceptibility candidate 2
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B2M
|
beta-2-microglobulin
|
|
B3GALTL
|
beta 1,3-galactosyltransferase-like
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCHE
|
butyrylcholinesterase
|
|
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide
|
|
BCKDK
|
branched chain ketoacid dehydrogenase kinase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BEST2
|
bestrophin 2
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLVRA
|
biliverdin reductase A
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP2
|
BCL2/adenovirus E1B 19kDa interacting protein 2
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C8A
|
complement component 8, alpha polypeptide
|
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
|
CA9
|
carbonic anhydrase IX
|
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALML5
|
calmodulin-like 5
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN3
|
calpain 3, (p94)
|
|
CAPN6
|
calpain 6
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCDC40
|
coiled-coil domain containing 40
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD14
|
CD14 molecule
|
|
CD24
|
CD24 molecule
|
|
CD247
|
CD247 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD63
|
CD63 molecule
|
|
CD82
|
CD82 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEL
|
carboxyl ester lipase
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGN
|
cingulin
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLDN16
|
claudin 16
|
|
CLDN2
|
claudin 2
|
|
CLDN4
|
claudin 4
|
|
CLK1
|
CDC-like kinase 1
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CLOCK
|
clock circadian regulator
|
|
CLRN1
|
clarin 1
|
|
CLU
|
clusterin
|
|
CMIP
|
c-Maf inducing protein
|
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family)
|
|
CNIH1
|
cornichon family AMPA receptor auxiliary protein 1
|
|
CNTNAP5
|
contactin associated protein-like 5
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COL9A2
|
collagen, type IX, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS6
|
COP9 signalosome subunit 6
|
|
COQ7
|
coenzyme Q7 homolog, ubiquinone (yeast)
|
|
CORO7
|
coronin 7
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRB2
|
crumbs family member 2
|
|
CRBN
|
cereblon
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CSPP1
|
centrosome and spindle pole associated protein 1
|
|
CSTA
|
cystatin A (stefin A)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CUX1
|
cut-like homeobox 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXXC1
|
CXXC finger protein 1
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYGB
|
cytoglobin
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
DAD1P1
|
defender against cell death 1 pseudogene 1
|
|
DAO
|
D-amino-acid oxidase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DCTN1
|
dynactin 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DEAF1
|
DEAF1 transcription factor
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB104A
|
defensin, beta 104A
|
|
DEFB104B
|
defensin, beta 104B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEL7Q11.23
|
Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb
|
|
DGKH
|
diacylglycerol kinase, eta
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIRC2
|
disrupted in renal carcinoma 2
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DMRT1
|
doublesex and mab-3 related transcription factor 1
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOCK4
|
dedicator of cytokinesis 4
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK7
|
docking protein 7
|
|
DPF2
|
D4, zinc and double PHD fingers family 2
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRC1
|
dynein regulatory complex subunit 1
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSP
|
desmoplakin
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DYM
|
dymeclin
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECHS1
|
enoyl CoA hydratase, short chain, 1, mitochondrial
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDA
|
ectodysplasin A
|
|
EFNA2
|
ephrin-A2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EHF
|
ets homologous factor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
EMD
|
emerin
|
|
EN1
|
engrailed homeobox 1
|
|
ENAM
|
enamelin
|
|
ENG
|
endoglin
|
|
ENOX2
|
ecto-NOX disulfide-thiol exchanger 2
|
|
ENSA
|
endosulfine alpha
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETM2
|
essential tremor 2
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
F11
|
coagulation factor XI
|
|
F11R
|
F11 receptor
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F8A1
|
coagulation factor VIII-associated 1
|
|
FABP12
|
fatty acid binding protein 12
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBL
|
fibrillarin
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FBN1
|
fibrillin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FECH
|
ferrochelatase
|
|
FERMT1
|
fermitin family member 1
|
|
FERMT2
|
fermitin family member 2
|
|
FERMT3
|
fermitin family member 3
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGGY
|
FGGY carbohydrate kinase domain containing
|
|
FHIT
|
fragile histidine triad
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FKBP10
|
FK506 binding protein 10, 65 kDa
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKRP
|
fukutin related protein
|
|
FLCN
|
folliculin
|
|
FLG
|
filaggrin
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FN3K
|
fructosamine 3 kinase
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXC1
|
forkhead box C1
|
|
FOXG1
|
forkhead box G1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FRA16D
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
FRG2
|
FSHD region gene 2
|
|
FRMD7
|
FERM domain containing 7
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FZD6
|
frizzled class receptor 6
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GALE
|
UDP-galactose-4-epimerase
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS5
|
growth arrest-specific 5 (non-protein coding)
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA6
|
GATA binding protein 6
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF5
|
growth differentiation factor 5
|
|
GDF6
|
growth differentiation factor 6
|
|
GDF7
|
growth differentiation factor 7
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GJC3
|
gap junction protein, gamma 3, 30.2kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GLE1
|
GLE1 RNA export mediator
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRB
|
glycine receptor, beta
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPD2
|
glycerol-3-phosphate dehydrogenase 2 (mitochondrial)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRHL3
|
grainyhead-like 3 (Drosophila)
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN3B
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRK6
|
G protein-coupled receptor kinase 6
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSS
|
glutathione synthetase
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HADH
|
hydroxyacyl-CoA dehydrogenase
|
|
HADHA
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit
|
|
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBG1
|
hemoglobin, gamma A
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC6
|
histone deacetylase 6
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H3I
|
histone cluster 1, H3i
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNMT
|
histamine N-methyltransferase
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F
|
|
HOPX
|
HOP homeobox
|
|
HOXA10
|
homeobox A10
|
|
HOXA11
|
homeobox A11
|
|
HOXB4
|
homeobox B4
|
|
HOXD13
|
homeobox D13
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH3
|
histamine receptor H3
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDS
|
iduronate 2-sulfatase
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFRD1
|
interferon-related developmental regulator 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IHH
|
indian hedgehog
|
|
IK
|
IK cytokine, down-regulator of HLA II
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL18RAP
|
interleukin 18 receptor accessory protein
|
|
IL1B
|
interleukin 1, beta
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL37
|
interleukin 37
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INHA
|
inhibin, alpha
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KALRN
|
kalirin, RhoGEF kinase
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE3
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNH3
|
potassium channel, voltage gated eag related subfamily H, member 3
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDR
|
kinase insert domain receptor
|
|
KIF11
|
kinesin family member 11
|
|
KIF17
|
kinesin family member 17
|
|
KIF18A
|
kinesin family member 18A
|
|
KIF22
|
kinesin family member 22
|
|
KIF2C
|
kinesin family member 2C
|
|
KIF4A
|
kinesin family member 4A
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT1
|
keratin 1, type II
|
|
KRT12
|
keratin 12, type I
|
|
KRT14
|
keratin 14, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT9
|
keratin 9, type I
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAT
|
linker for activation of T cells
|
|
LCA5
|
Leber congenital amaurosis 5
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LECT2
|
leukocyte cell-derived chemotaxin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX3
|
LIM homeobox 3
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LIPC
|
lipase, hepatic
|
|
LIPH
|
lipase, member H
|
|
LMF1
|
lipase maturation factor 1
|
|
LMNA
|
lamin A/C
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOR
|
loricrin
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
LPIN2
|
lipin 2
|
|
LPL
|
lipoprotein lipase
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LUC7L3
|
LUC7-like 3 (S. cerevisiae)
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAGT1
|
magnesium transporter 1
|
|
MALT1
|
MALT1 paracaspase
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MATN3
|
matrilin 3
|
|
MAU2
|
MAU2 sister chromatid cohesion factor
|
|
MAX
|
MYC associated factor X
|
|
MBNL2
|
muscleblind-like splicing regulator 2
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCOLN1
|
mucolipin 1
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDH2
|
malate dehydrogenase 2, NAD (mitochondrial)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED22
|
mediator complex subunit 22
|
|
MED23
|
mediator complex subunit 23
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2B
|
myocyte enhancer factor 2B
|
|
MEIS1
|
Meis homeobox 1
|
|
MESDC2
|
mesoderm development candidate 2
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MFRP
|
membrane frizzled-related protein
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR132
|
microRNA 132
|
|
MIR135B
|
microRNA 135b
|
|
MIR141
|
microRNA 141
|
|
MIR146A
|
microRNA 146a
|
|
MIR149
|
microRNA 149
|
|
MIR155
|
microRNA 155
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR1827
|
microRNA 1827
|
|
MIR184
|
microRNA 184
|
|
MIR200C
|
microRNA 200c
|
|
MIR21
|
microRNA 21
|
|
MIR212
|
microRNA 212
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR219A1
|
microRNA 219a-1
|
|
MIR22
|
microRNA 22
|
|
MIR221
|
microRNA 221
|
|
MIR371A
|
microRNA 371a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MLH3
|
mutL homolog 3
|
|
MLYCD
|
malonyl-CoA decarboxylase
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPEG1
|
macrophage expressed 1
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPZ
|
myelin protein zero
|
|
MR1P1
|
major histocompatibility complex, class I-related pseudogene
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTMR12
|
myotubularin related protein 12
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MUTYH
|
mutY homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCKIPSD
|
NCK interacting protein with SH3 domain
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGFR
|
nerve growth factor receptor
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLN
|
neurolysin (metallopeptidase M3 family)
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NPAS2
|
neuronal PAS domain protein 2
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPTX2
|
neuronal pentraxin II
|
|
NPY
|
neuropeptide Y
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG3
|
neuregulin 3
|
|
NRXN1
|
neurexin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCB2
|
nucleobindin 2
|
|
NUP98
|
nucleoporin 98kDa
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OSBP
|
oxysterol binding protein
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PACRG
|
PARK2 co-regulated
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PALM2-AKAP2
|
PALM2-AKAP2 readthrough
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX4
|
paired box 4
|
|
PAX6
|
paired box 6
|
|
PAX9
|
paired box 9
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PCLO
|
piccolo presynaptic cytomatrix protein
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDCL
|
phosducin-like
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER1
|
period circadian clock 1
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PEX7
|
peroxisomal biogenesis factor 7
|
|
PFDN5
|
prefoldin subunit 5
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHF6
|
PHD finger protein 6
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PITX3
|
paired-like homeodomain 3
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP2
|
plakophilin 2
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCZ1
|
phospholipase C, zeta 1
|
|
PLEC
|
plectin
|
|
PLIN1
|
perilipin 1
|
|
PLK1
|
polo-like kinase 1
|
|
PLK2
|
polo-like kinase 2
|
|
PLK4
|
polo-like kinase 4
|
|
PLP1
|
proteolipid protein 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PLXNA2
|
plexin A2
|
|
PLXNB1
|
plexin B1
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POC1B
|
POC1 centriolar protein B
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLD3
|
polymerase (DNA-directed), delta 3, accessory subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLR1B
|
polymerase (RNA) I polypeptide B, 128kDa
|
|
POLR3G
|
polymerase (RNA) III (DNA directed) polypeptide G (32kD)
|
|
POMT1
|
protein-O-mannosyltransferase 1
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPOX
|
protoporphyrinogen oxidase
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROM1
|
prominin 1
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PRSS3
|
protease, serine, 3
|
|
PRUNE2
|
prune homolog 2 (Drosophila)
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PSMD8
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYGL
|
phosphorylase, glycogen, liver
|
|
PYGM
|
phosphorylase, glycogen, muscle
|
|
RAB28
|
RAB28, member RAS oncogene family
|
|
RAB2A
|
RAB2A, member RAS oncogene family
|
|
RAB3GAP2
|
RAB3 GTPase activating protein subunit 2 (non-catalytic)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RANBP2
|
RAN binding protein 2
|
|
RASA2
|
RAS p21 protein activator 2
|
|
RASL11A
|
RAS-like, family 11, member A
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBBP6
|
retinoblastoma binding protein 6
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM8A
|
RNA binding motif protein 8A
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCOR1
|
REST corepressor 1
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
REXO4
|
REX4, RNA exonuclease 4 homolog (S. cerevisiae)
|
|
RGN
|
regucalcin
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHAG
|
Rh-associated glycoprotein
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNASEH2A
|
ribonuclease H2, subunit A
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RRS1
|
RRS1 ribosome biogenesis regulator homolog (S. cerevisiae)
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A8
|
S100 calcium binding protein A8
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SCAND1
|
SCAN domain containing 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SEMA3D
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPC
|
surfactant protein C
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHH
|
sonic hedgehog
|
|
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial)
|
|
SI
|
sucrase-isomaltase (alpha-glucosidase)
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SIX3
|
SIX homeobox 3
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A4
|
solute carrier family 12 (potassium/chloride transporter), member 4
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7
|
|
SLC14A2
|
solute carrier family 14 (urea transporter), member 2
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC18A3
|
solute carrier family 18 (vesicular acetylcholine transporter), member 3
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC26A5
|
solute carrier family 26 (anion exchanger), member 5
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 3
|
|
SLC35D1
|
solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC47A1
|
solute carrier family 47 (multidrug and toxin extrusion), member 1
|
|
SLC52A2
|
solute carrier family 52 (riboflavin transporter), member 2
|
|
SLC52A3
|
solute carrier family 52 (riboflavin transporter), member 3
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5
|
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOST
|
sclerostin
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST2
|
suppression of tumorigenicity 2
|
|
ST3GAL3
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
|
|
ST3GAL5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STBMS1
|
Strabismus, susceptibility to, 1
|
|
STRN3
|
striatin, calmodulin binding protein 3
|
|
STX5
|
syntaxin 5
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SUOX
|
sulfite oxidase
|
|
SYNC
|
syncoilin, intermediate filament protein
|
|
SYNGAP1
|
synaptic Ras GTPase activating protein 1
|
|
TAC3
|
tachykinin 3
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBCB
|
tubulin folding cofactor B
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBL1X
|
transducin (beta)-like 1X-linked
|
|
TBP
|
TATA box binding protein
|
|
TBX21
|
T-box 21
|
|
TBX3
|
T-box 3
|
|
TBX5
|
T-box 5
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF3
|
transcription factor 3
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TCP1
|
t-complex 1
|
|
TCP10L
|
t-complex 10-like
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM1
|
transglutaminase 1
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THEM4
|
thioesterase superfamily member 4
|
|
THOP1
|
thimet oligopeptidase 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNKS2
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNPO3
|
transportin 3
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53I3
|
tumor protein p53 inducible protein 3
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPO
|
thyroid peroxidase
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIP11
|
thyroid hormone receptor interactor 11
|
|
TRNT1
|
tRNA nucleotidyl transferase, CCA-adding, 1
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSEN54
|
TSEN54 tRNA splicing endonuclease subunit
|
|
TSHB
|
thyroid stimulating hormone, beta
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSHZ1
|
teashirt zinc finger homeobox 1
|
|
TTC3
|
tetratricopeptide repeat domain 3
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTR
|
transthyretin
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUSC3
|
tumor suppressor candidate 3
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBE2Q1
|
ubiquitin-conjugating enzyme E2Q family member 1
|
|
UBE2S
|
ubiquitin-conjugating enzyme E2S
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UGT8
|
UDP glycosyltransferase 8
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
UMOD
|
uromodulin
|
|
UMODL1
|
uromodulin-like 1
|
|
USF1
|
upstream transcription factor 1
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP19
|
ubiquitin specific peptidase 19
|
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIPAS39
|
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VPS33B
|
vacuolar protein sorting 33 homolog B (yeast)
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VPS52
|
vacuolar protein sorting 52 homolog (S. cerevisiae)
|
|
VPS53
|
vacuolar protein sorting 53 homolog (S. cerevisiae)
|
|
VPS54
|
vacuolar protein sorting 54 homolog (S. cerevisiae)
|
|
VRK1
|
vaccinia related kinase 1
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP57
|
ZFP57 zinc finger protein
|
|
ZIC3
|
Zic family member 3
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
|
ZNF143
|
zinc finger protein 143
|
|
ZSCAN21
|
zinc finger and SCAN domain containing 21
|
